A novel calcium-binding protein is associated with tau proteins in tauopathy

Journal of Neurochemistry

Volumn 106, Issue 1, 2008, Pages 96-106

  Vega, Irving E ^a,c   Traverso, Edwin E ^a   Ferrer Acosta, Yancy ^a   Matos, Eduardo ^a   Colon, Migdalisel ^a   Gonzalez, John ^b   Dickson, Dennis ^b   Hutton, Michael ^b   Lewis, Jada ^b   Yen, Shu H ^b  

^a UNIVERSITY OF PUERTO RICO RIO PIEDRAS   (Puerto Rico)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Alzheimer's disease; Calcium; EF hand domain; Tau; Tauopathy

Indexed keywords

CALCIUM BINDING PROTEIN; SWIPROSIN 1; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; TAUOPATHY;

AGING; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; CALCIUM; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; EF HAND MOTIFS; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NEURONS; TAU PROTEINS; TAUOPATHIES;

MUS; MUS MUSCULUS;

EID: 45249099292     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05339.x     Document Type: Article

References (32)

1. Ahlijanian M. K., Barrezueta N. X., Williams R. D. et al. (2000) Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc. Natl Acad. Sci. USA 97, 2910 2915.
2. Avramidou A., Kroczek C., Lang C., Schuh W., Jäck H.-M. Mielenz D (2007) The novel adaptor protein Swiprosin 1 enhances BCR signals and contributes to BCR-induced apoptosis. Cell Death Differ. 14, 1936 1947.
3. Ballatore C., Lee V. M.-Y. Trojanowski J. Q. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8, 663 672.
4. Berger Z., Roder H., Hanna A. et al. (2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J. Neurosci. 27, 3650 3662.
5. Cruz J. C., Tseng H. C., Goldman J. A., Shih H. Tsai L. H. (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471 483.
6. Dickey C., Dunmore J., Lu B. et al. (2006) HSP induction mediates selective clearance of tau phosphorylated at praline-directed Ser/Thr sites but not KXGS (MARK) sites. FASEB J. 20, 753 755.
7. Dickey C. A., Kamal A., Lundgren K. et al. (2007) The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J. Clin. Invest. 117, 648 658.
8. Dou F., Netzer W. J., Tanemura K. et al. (2003) Chaperones increase association of tau proteins with mircotubules. Proc. Natl Acad. Sci. USA 100, 721 726.
9. Fulga T. A., Elson-Schwab I., Khurana V. et al. (2007) Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat. Cell Biol. 9, 139 148.
10. Hanger D. P., Hughes K., Woodgett J. R., Brion J. P. Anderton B. H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired-helical filament epitopes and neuronal localization of the kinase. Neurosci. Lett. 147, 58 62.
11. Hardy J. (2006) A hundred years of Alzheimer's disease research. Neuron 52, 3 13.
12. Hernandez F. Avila J. (2007) Tauopathies. Cell. Mol. Life Sci. 64, 2219 2233.
13. Hodges J. R. (2006) Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects. Brain 129, 2811 2822.
14. 2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126, 981 993.
15. Le Corre S., Klafki H. W., Plesnila N. et al. (2006) An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proc. Natl Acad. Sci. USA 103, 9673 9678.
16. Lee M. S. Tsai L. H. (2003) Cdk5: one of the links between senile plaques and neurofibrillary tangles? J. Alzheimers Dis. 5, 127 137.
17. Lee V. M.-Y., Goedert M. Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121 1159.
18. Lewis J., McGowan E., Rockwood J. et al. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Gen. 25, 402 405.
19. Lucas J. J., Hernandez F., Gomez-Ramos P., Moran M. A., Hen R. Avila J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3 beta conditional transgenic mice. EMBO J. 20, 27 39.
20. Nelson M. R., Thulin E., Fagan P. A., Forsen S. Chazin W. J. (2002) The EF-hand domain: a globally cooperative structural unit. Protein Sci. 11, 198 205.
21. Oddo S., Billings L., Kesslak J. P., Cribbs D. H. LaFerla F. M. (2004) Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321 332.
22. Olivier T., Gant J. C. Landfiled P. W. (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 6, 307 317.
23. Petrucelli L., Dickson D., Kehoe K., Taylor J. et al. (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13, 703 714.
24. Roberson E. D., Scearce-Levie K., Palop J. J. et al. (2007) Reducing endogenous tau ameliorates amyloid b-induced deficits in an Alzheimer's disease mouse model. Science 316, 750 754.
25. Sahara N, Lewis J., DeTure M., McGowan E., Dickson D. W., Hutton M. Yen S. H. (2002) Assembly of tau in transgenic animals expressing P301L tau: alterations of phosphorylation and solubility. J. Neurochem. 83, 1498 1508.
26. Sengupta A., Wu Q., Grundke-Iqbal I., Iqbal K. Singh T. J. (1997) Potentiation of GSK-3 catalyzed Alzheimer-like phosphorylation of human tau by cdk5. Mol. Cell. Biochem. 167, 99 105.
27. Shimura H., Schwartz D., Gygi S. P. Kosik K. S. (2004) CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 279, 4869 4876.
28. The RIKEN Genome Exploration Research Group I & II Team and the FANTOM Consortium (2002) Analysis of the mouse transcriptome base on functional annotation of 60,770 full-length cDNA. Nature 420 : 563 573.
29. The RIKEN Genome Exploration Research Group Phase II Team and the FANTOM Consortium 2001) Functional annotation of 21,076 sequenced mouse cDNA prepared from full-length enriched libraries. Nature 409, 685 690.
30. Vega I. E., Cui L., Props J. A. et al. (2005) Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates. Mol. Brain Res. 138, 135 144.
31. Vuadens F., Rufer N., Kress A., Corthesy P., Schneider P. Tissot J. D. (2004) Identification of swiprosin 1 in human lymphocytes. Proteomics 4, 2216 2220.
32. Wang J. Z., Grundke-Iqbal I. Iqbal K. (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci. 25, 59 68.